Cellivery Therapeutics (268600) Stock Overview

Cellivery Therapeutics, Inc. researches and develops therapeutic drugs for life-threatening diseases comprising cancer, inflammation, metabolic, and neurodegenerative diseases. It develops small molecule, antibody, and vaccine drugs based on its therapeutic molecule systemic delivery technology. The company was incorporated in 2014 and is based in Seoul, South Korea.